@article{fa06fd1204d5462795f133671de852d5,
title = "Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer",
author = "Vivek Verma and Simone, \{Charles B.\} and Allen, \{Pamela K.\} and Gajjar, \{Sameer R.\} and Chirag Shah and Weining Zhen and Harkenrider, \{Matthew M.\} and Hallemeier, \{Christopher L.\} and Jabbour, \{Salma K.\} and Matthiesen, \{Chance L.\} and Braunstein, \{Steve E.\} and Percy Lee and Dilling, \{Thomas J.\} and Allen, \{Bryan G.\} and Nichols, \{Elizabeth M.\} and Albert Attia and Jing Zeng and Tithi Biswas and Peter Paximadis and Fen Wang and Walker, \{Joshua M.\} and Stahl, \{John M.\} and Daly, \{Megan E.\} and Decker, \{Roy H.\} and Hales, \{Russell K.\} and Henning Willers and Videtic, \{Gregory M.M.\} and Mehta, \{Minesh P.\} and Lin, \{Steven H.\}",
note = "For inoperable stage I (T1-T2N0) small cell lung cancer (SCLC), national guidelines recommend chemotherapy with or without conventionally fractionated radiation therapy. The present multi-institutional cohort study investigated the role of stereotactic ablative radiation therapy (SABR) for this population.",
year = "2017",
month = jan,
day = "2",
doi = "10.1016/j.ijrobp.2016.10.041",
language = "American English",
volume = "97",
journal = "International Journal of Radiation Oncology Biology Physics",
}